$38.00—Stale · 2.1 years old
NASDAQ • Last print 2.1 years ago
$38.00—Stale · 2.1 years old
Though Potential Bidders Moved Away, Amgen's Bid For Five Prime Outlasted 15 Suitors
FPRX Stock Price Increases 78.74% On Amgen Acquisition News
Amgen Pays $1.9B For Five Prime Therapeutics Acquisition
Amgen to buy Five Prime Therapeutics in a deal valued at $1.9 billion to boost cancer treatment portfolio
Five Prime's Stock Quadruples On Positive Mid-Stage Stomach Cancer Study
Five Prime Therapeutics soars 386% after positive cancer trial results (FPRX)
Five Prime's stock rockets fourfold after positive trial results from cancer treatment, analyst upgrade
Recap: Five Prime Therapeutics Q3 Earnings
Five Prime Therapeutics (NASDAQ:FPRX) Stock Rating Upgraded by Zacks Investment Research